Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
3.
Rev Esp Med Nucl ; 27(4): 253-8, 2008.
Artículo en Español | MEDLINE | ID: mdl-18682151

RESUMEN

OBJECTIVE: To analyse the behaviour of serum thyroglobulin (Tg), antithyroglobulin antibodies (TgAb), thyrotropin (TSH), free thyroxine (FT4) and total triiodothyronine (TT3) levels at each time during the rhTSH stimulation protocol in patients with differentiated thyroid carcinoma (DTC). MATERIALS AND METHODS: We carried out 117 rhTSH stimulations in DTC patients. We determined the serum levels of Tg, TgAb, TSH, FT4 and TT3 at baseline and 24, 48 and 96 hours after beginning stimulation, using RIA or IRMA. The software program SPSS 15.0 was used for statistical analysis of data. RESULTS: We found statistically significant differences between the mean Tg values at different times (2.08 ng/ml baseline; 2.64 ng/ml at 24 hours; 4.98 ng/ml at 48 hours; 6.59 ng/ml at 96 hours), reaching maximum values at 96 hours. During this time, we observed the highest percentage of pathological values. After administration of rhTSH, there was a significant increase in the mean TSH value (98.88 mIU/l at 24 hours; 111.10 mIU/l at 48 hours). The mean TSH value at 96 hours decreased approximately 5 times with respect to the mean 48 hour value. We did not observe changes in the TgAb, FT4 or TT3 levels. CONCLUSIONS: The assessment of Tg after rhTSH stimulation should be performed 96 hours after beginning stimulation. Administration of rhTSH causes a significant elevation in serum TSH levels, without modifying serum TgAb, FT4 or TT3 levels.


Asunto(s)
Autoanticuerpos/sangre , Carcinoma/sangre , Proteínas Recombinantes , Tiroglobulina/sangre , Tiroglobulina/inmunología , Neoplasias de la Tiroides/sangre , Tirotropina/sangre , Tiroxina/sangre , Triyodotironina/sangre , Humanos , Factores de Tiempo
4.
Rev Esp Med Nucl ; 26(2): 90-9, 2007.
Artículo en Español | MEDLINE | ID: mdl-17386235

RESUMEN

INTRODUCTION: The need for quality assurance of all technical aspects of nuclear medicine studies is widely recognised. However, little attention has been paid to the quality assurance of the applications software. Our work reported here aims at verifying the analysis software for processing of renal nuclear medicine studies (renograms). MATERIAL AND METHODS: The software tools were used to build a synthetic dynamic model of renal system. The model consists of two phases: perfusion and function. The organs of interest (kidneys, bladder and aortic artery) were simple geometric forms. The uptake of the renal structures was described by mathematic functions. Curves corresponding to normal or pathological conditions were simulated for kidneys, bladder and aortic artery by appropriate selection of parameters. RESULTS: There was no difference between the parameters of the mathematic curves and the quantitative data produced by the renal analysis program. CONCLUSION: Our test procedure is simple to apply, reliable, reproducible and rapid to verify the renal applications software.


Asunto(s)
Aorta Abdominal/diagnóstico por imagen , Procesamiento de Imagen Asistido por Computador/normas , Riñón/diagnóstico por imagen , Medicina Nuclear/normas , Fantasmas de Imagen , Garantía de la Calidad de Atención de Salud , Programas Informáticos/normas , Vejiga Urinaria/diagnóstico por imagen , Algoritmos , Simulación por Computador , Humanos , Procesamiento de Imagen Asistido por Computador/métodos , Perfusión , Cintigrafía , Radiofármacos/análisis , Radiofármacos/farmacocinética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA